 |
 |
 |
 |
 |
 |
News from SGC
Posted on Wednesday 28th of September 2011
A research team led by scientists from Oxford University (including the Structural Genomics Consortium, the Botnar Research Centre, the Weatherall Institute of Molecular Medicine, the Wellcome Building for Molecular Physiology, and the australian Diamantina Institute in Brisbane), have successfully deciphered the molecular mechanism how an ER protease (ERAP1) functions in a key step in cellular immunity- the processing of peptide antigens that are presented to Major Histocompatibilty Complex 1 (MHC1) molecules.
Posted on Tuesday 27th of September 2011
The Structural Genomic Consortium (SGC) announced today that SGC and Cerep, a worldleading biotechnology company, will enter into a collaboration to develop open access biochemical and cell-based assays for the discovery of small molecule chemical probes and drug candidates on epigenetic targets. As part of the collaboration, Cerep will open a laboratory in Toronto from which it will offer its screening and profiling services.
Posted on Tuesday 27th of September 2011
Posted on Monday 25th of July 2011
As part of the celebrations, Wellcome Trust researchers from the SGC, the Department of Zoology, the University Museum of Natural History and the Museum of History of Science at the University of Oxford present a stimulating series of events.
Posted on Thursday 1st of March 2007
Structural Genomics Consortium reaches project milestone ahead of schedule
Posted on Monday 23rd of May 2005
New spectrum of human drug targets identified and available to all to research
Posted on Wednesday 2nd of April 2003
Research looks to unravel mysteries of over 350 proteins and lead to new products for unmet medical needs
Pages
